巨噬细胞清道夫受体1介导非酒精性脂肪性肝病中的脂质诱导性炎症
该研究通过170例非酒精性脂肪性肝病(NAFLD)肝活检转录组分析、Msr1基因敲除与野生型小鼠高脂高胆固醇饮食模型、以及针对MSR1的单克隆抗体干预实验,发现MSR1表达与肝脏脂质负载泡沫巨噬细胞的出现及脂肪变性和脂肪性肝炎程度相关,MSR1通过JNK信号通路介导促炎反应,阻断MSR1可预防泡沫巨噬细胞形成和炎症,提示MSR1是NAFLD的潜在治疗靶点。
要点
- MSR1表达与NAFLD患者肝脏泡沫巨噬细胞出现及脂肪变性和脂肪性肝炎程度相关。
- Msr1缺失小鼠对饮食诱导的代谢紊乱有保护作用,肝脏泡沫巨噬细胞和炎症减少。
- 单克隆抗体靶向MSR1可预防肥胖相关NAFLD小鼠模型和人类肝切片中的泡沫巨噬细胞形成和炎症。
核心结论
- MSR1在脂质诱导的炎症中起关键作用,可能是治疗NAFLD的潜在治疗靶点。
研究设计与样本
- 对170例NAFLD肝活检进行转录组分析并与临床病理特征关联。
- 使用Msr1-/-和野生型小鼠进行16周高脂高胆固醇饮食实验。
- 小鼠和离体人肝切片接受抗MSR1单克隆抗体治疗。
- 利用1483例NAFLD患者和430101名英国生物银行参与者的全基因组关联研究数据评估遗传易感性。
主要发现
- MSR1表达与NAFLD患者肝脏脂质负载泡沫巨噬细胞的出现相关,并与脂肪变性和脂肪性肝炎程度相关。
- Msr1缺失小鼠对饮食诱导的代谢紊乱有保护作用,表现为肝脏泡沫巨噬细胞减少、肝脏炎症减轻、血脂异常和葡萄糖耐量改善以及肝脏脂质代谢改变。
- 饱和脂肪酸诱导后,MSR1通过JNK信号通路诱导促炎反应。
- 体外阻断该受体可阻止原代巨噬细胞中脂质积累,抑制向促炎表型的转换和TNF-α等细胞因子的释放。
- 在肥胖相关NAFLD小鼠模型和人类肝切片中,使用单克隆抗体靶向MSR1可预防泡沫巨噬细胞形成和炎症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Obesity-associated inflammation is a key player in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). However, the role of macrophage scavenger receptor 1 (MSR1, CD204) remains incompletely understood. METHODS: A total of 170 NAFLD liver biopsies were processed for transcriptomic analysis and correlated with clinicopathological features. Msr1-/- and wild-type mice were subjected to a 16-week high-fat and high-cholesterol diet. Mice and ex vivo human liver slices were treated with a monoclonal antibody against MSR1. Genetic susceptibility was assessed using genome-wide association study data from 1,483 patients with NAFLD and 430,101 participants of the UK Biobank. RESULTS: MSR1 expression was associated with the occurrence of hepatic lipid-laden foamy macrophages and correlated with the degree of steatosis and steatohepatitis in patients with NAFLD. Mice lacking Msr1 were protected against diet-induced metabolic disorder, showing fewer hepatic foamy macrophages, less hepatic inflammation, improved dyslipidaemia and glucose tolerance, and altered hepatic lipid metabolism. Upon induction by saturated fatty acids, MSR1 induced a pro-inflammatory response via the JNK signalling pathway. In vitro blockade of the receptor prevented the accumulation of lipids in primary macrophages which inhibited the switch towards a pro-inflammatory phenotype and the release of cytokines such as TNF-ɑ. Targeting MSR1 using monoclonal antibody therapy in an obesity-associated NAFLD mouse model and human liver slices resulted in the prevention of foamy macrophage formation and inflammation. Moreover, we identified that rs41505344, a polymorphism in the upstream transcriptional region of MSR1, was associated with altered serum triglycerides and aspartate aminotransferase levels in a cohort of over 400,000 patients. CONCLUSIONS: Taken together, our data suggest that MSR1 plays a critical role in lipid-induced inflammation and could thus be a potential therapeutic target for the treatment of NAFLD. LAY SUMMARY: Non-alcoholic fatty liver disease (NAFLD) is a chronic disease primarily caused by excessive consumption of fat and sugar combined with a lack of exercise or a sedentary lifestyle. Herein, we show that the macrophage scavenger receptor MSR1, an innate immune receptor, mediates lipid uptake and accumulation in Kupffer cells, resulting in liver inflammation and thereby promoting the progression of NAFLD in humans and mice.
引用
- Govaere O, Petersen SK, Martinez-Lopez N, et al. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease. J Hepatol. 2021. PMID: 34942286. doi:10.1016/j.jhep.2021.12.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。